The Biologic Basis of Hernia Formation

The study will examine potential biological and genetic mechanisms leading to hiatal and paraesophageal hernia formation in predisposed individuals. It is expected that these patients will have defects in the normal production and maturation of collagen and other connective tissue proteins, thus leading to weakness in the diaphragm that may allow for spontaneous herniation. Comparison of tissue and blood samples from these patients (study group) will be made to those from individuals undergoing lower esophageal surgery who have not developed a concurrent hernia (i.e. esophageal myotomy for achalasia and laparoscopic gastric bypass or laparoscopic adjustable gastric banding for morbid obesity - control group).

Study Overview

Status

Completed

Detailed Description

Diaphragmatic herniation is a common medical problem characterized by protrusion of the abdominal viscera directly through (95% of cases), or adjacent to (5% of cases), the esophageal hiatus. Individuals suffering from these so-called hiatal and paraesophageal hernias experience symptoms such as regurgitation, heartburn, early satiety, and in extreme cases, respiratory compromise or visceral strangulation and ischemia. Unless the hernia is small, these symptoms are generally refractory to medical management and require surgical correction, with approximately 40,000 antireflux surgeries being performed each year in the United States. The hernia repair procedure, which may be performed in either a laparoscopic or open fashion, involves reduction of the intrathoracic viscera back into the abdominal cavity and closure of the diaphragmatic defect. Generally, this closure of the hernia can be accomplished primarily, using nonabsorbable suture to approximate the edges of the defect. Unfortunately, the recurrence rate for this type of repair is unacceptably high and ranges from 10-40%. Furthermore, in the instance of a particularly large hernia, the edges of the defect may be too far apart to be primarily brought together, necessitating the use of other strategies such as relaxing incisions or patches to bridge the gap. Although the precise recurrence rates of these complex repairs is not clear, it is expected that they are even higher that for those diaphragmatic hernias that can be closed primarily.

The genetic and biologic factors that predispose individuals to forming hernias are not well understood. Several smaller series have suggested that ventral and inguinal hernia formation may be due to weakness of the abdominal wall, possibly secondary to defects in collagen deposition and metabolism. Certain studies have shown higher ratios of Type III collagen (immature) to Type I collagen (mature), at both the protein and mRNA level, in patients with abdominal hernias as compared to those without. Furthermore, other reports indicate that these differences in the levels of mature collagen might be due to underlying differences ion the expression of certain matrix metalloproteinase (MMPs), which are largely responsible for collagen remodeling. MMPs -1, -2, -3, -9, and -13 have been shown to be upregulated in connective tissue injury, and alterations in both MMP-2 and fibrillar collagen can interfere with normal wound healing. Furthermore, Bellon et. al. have shown an overexpression of MMP-2 in fibroblasts in patients with direct inguinal hernias, and Zheng's group detected MMP-13 overexpression in tissue samples from patients with recurrent inguinal hernias. So far, no studies have addressed the role of collagen deposition and MMPs in the formation of hiatal and paraesophageal hernias. Preliminary work at our institution has, however, shown a greater than 50% reduction in the elastin content of the phrenoesophageal and gastrohepatic ligaments ("PEL" and "GHL", respectively) of those patients with a hiatal hernia compared to those without herniation. Additionally, the elastic fibers in the PEL and GHL frequently displayed fragmentation and distortion despite the lack of a visible inflammatory response. (J.A. Curci and N.J. Soper, unpublished results) Nevertheless, neither our early work, nor any of the studies from outside institutions have looked at ways of screening patients (i.e. via blood sampling) to detect those at a higher risk for such hernia occurrence. Currently, new MMP-inhibitory drugs are being studied as methods to potentially block or slow the development of other MMP-dependent conditions such as abdominal aortic aneurysm (AAA). Along these lines, if patients with a genetic/biologic predisposition to hernia formation could be readily identified, then this presents a potential point of medical intervention in preventing future hernia development.

Research procedures:

Patients to be enrolled in the study will be standard referrals to our group from primary care physicians or other specialists who feel that surgical correction of a diaphragmatic hernia or achalasia is necessary. Additionally, patients referred to our practice for weight reduction surgery will also be considered eligible for enrollment.

Consent to participate in the study will occur at the time of consent to the surgical procedure and will be obtained by the PI and other attending surgeons within the minimally invasive surgery group. This will occur in the surgeon's office/clinic, or in the hospital if the patient is an in-house consult, several days to weeks prior to the scheduled surgery.

Following the informed consent process, patients will be appropriately placed in either the study or control group. At the time of surgery (hernia repair, bariatric procedure, or esophageal myotomy), a 30 ml venous blood sample will be drawn and stored for later testing and analysis. The appropriate standard surgical procedure will then be performed as per surgical attending judgment, however, during the operation, a small (approximately 1 cm2) piece of tissue will be excised from each of 3 anatomic sites: 1) the left diaphragmatic crus, 2) the PEL, and 3) the GHL. After removal from the abdomen, these tissue samples will be divided into 2 pieces to be set aside for further testing at a later time.

This excised samples represent a minute amount of tissue when compared to the overall size of the diaphragmatic crura and surrounding ligamentous attachments, and their removal is not be expected to cause any foreseeable problem for the patient. In fact, hiatal hernia repair often necessitates dissection of much larger crural and connective tissue pieces than this in order to obtain complete reduction of the abdominal viscera out of the chest and subsequent closure of the hernia defect. Following removal of these small tissue samples, the hernia repair, esophageal myotomy, or gastric bypass/banding will then be completed in a standard fashion.

Inclusion Criteria: Any patient undergoing paraesophageal hernia repair, esophageal myotomy, laparoscopic gastric bypass, or laparoscopic adjustable gastric banding.

Exclusion Criteria: Pregnant females, minors, prisoners

Study Type

Observational

Enrollment (Actual)

151

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Saint Louis, Missouri, United States, 63110
        • Washington University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients to be enrolled in the study will be standard referrals to our group from primary care physicians or other specialists who feel that surgical correction of a diaphragmatic hernia or achalasia is necessary. Additionally, patients referred to our practice for weight reduction surgery will also be considered eligible for enrollment.

Description

Inclusion Criteria:

  • Any patient undergoing paraesophageal hernia repair, esophageal myotomy, laparoscopic gastric bypass, or laparoscopic adjustable gastric banding.

Exclusion Criteria:

  • Pregnant females, minors, prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Hiatal/Paraesophageal hernia patients
patients with hiatal or paraesophageal hernias
control group
patients without hiatal or paraesophageal hernias who are undergoing crural dissection for heller myotomy, or who are undergoing gastric bypass surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brent D Matthews, MD, Washington University School of Medicine
  • Study Director: Corey Deeken, PhD, Washington University School of Medicine
  • Study Chair: Peggy Frisella, RN, Washington University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Primary Completion (Actual)

October 1, 2011

Study Completion (Actual)

October 1, 2011

Study Registration Dates

First Submitted

April 2, 2010

First Submitted That Met QC Criteria

April 5, 2010

First Posted (Estimate)

April 6, 2010

Study Record Updates

Last Update Posted (Actual)

May 14, 2018

Last Update Submitted That Met QC Criteria

May 7, 2018

Last Verified

May 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hiatal Hernia

3
Subscribe